0001493152-20-003823.txt : 20200312 0001493152-20-003823.hdr.sgml : 20200312 20200312163452 ACCESSION NUMBER: 0001493152-20-003823 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200310 FILED AS OF DATE: 20200312 DATE AS OF CHANGE: 20200312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALTIG ANTHONY E CENTRAL INDEX KEY: 0001215907 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51030 FILM NUMBER: 20709276 MAIL ADDRESS: STREET 1: C/O OPTIMER PHARMACEUTICALS, INC STREET 2: 101 HUDSON STREET CITY: JERSEY CITY STATE: NJ ZIP: 07302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TearLab Corp CENTRAL INDEX KEY: 0001299139 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 593434771 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9980 HUENNEKENS ST. STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-794-1400 MAIL ADDRESS: STREET 1: 9980 HUENNEKENS ST. STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: OccuLogix, Inc. DATE OF NAME CHANGE: 20040730 4 1 ownership.xml X0306 4 2020-03-10 0 0001299139 TearLab Corp TEAR 0001215907 ALTIG ANTHONY E 150 LA TERRAZA BLVD., STE 101 ESCONDIDO, CA 92025 1 0 0 0 Stock Option (right to buy) 0.0312 2020-03-10 4 A 0 60000 0.00 A 2030-03-10 Common Stock 60000 60000 D One hundred percent (100%) of the shares subject to the Option shall be vested and exercisable upon the date of grant. Exhibit 24 - Power of Attorney /s/ Michael Marquez, as Attorney-in-Fact 2020-03-11 EX-24 2 ex24.htm

 

Exhibit 24

 

POWER OF ATTORNEY

 

The undersigned, as a Section 16 reporting person of TearLab Corporation (the “Company”), hereby constitutes and appoints Michael Marquez, Leslie Miller, Tom Hornish, Ben Capps and Tim Conroy as the undersigned’s true and lawful attorneys-in-fact to:

 

  1. complete and execute Forms 3, 4 and 5 and other forms and all amendments thereto as such attorney-in-fact shall in his or her discretion determine to be required or advisable pursuant to Section 16 of the Securities Exchange Act of 1934 (as amended) and the rules and regulations promulgated thereunder, or any successor laws and regulations, as a consequence of the undersigned’s ownership, acquisition or disposition of securities of the Company; and
     
  2. do all acts necessary in order to file such forms with the Securities and Exchange Commission, any securities exchange or national association, the Company and such other person or agency as the attorney-in-fact shall deem appropriate.

 

The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 (as amended).

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorney-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 11th day of March, 2020.

 

  Signature: /s/ Anthony E. Altig
     
  Print Name: Anthony E. Altig